US HB3223 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 12 2019 - 25% progression, died in committee
Action: 2019-06-13 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 12 2019 - 25% progression, died in committee
Action: 2019-06-13 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the Government Accountability Office to study the role of pharmacy benefit managers (PBMs) with respect to federally facilitated exchanges, including the role of PBMs in pharmaceutical supply chains, the competition among PBMs, and the use of rebates and fees by PBMs in such exchanges.
Title
Pharmacy Benefit Manager Accountability Study Act of 2019
Sponsors
| Sen. Roger Marshall [R-KS] | Sen. Peter Welch [D-VT] | Rep. Earl Carter [R-GA] | Rep. Vicente Gonzalez [D-TX] |
| Rep. Cindy Axne [D-IA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-06-13 | House | Referred to the Subcommittee on Health. |
| 2019-06-12 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-06-12 | House | Introduced in House |
Subjects
Competition and antitrust
Congressional oversight
Consumer affairs
Drug therapy
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Inflation and prices
Prescription drugs
User charges and fees
Congressional oversight
Consumer affairs
Drug therapy
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Inflation and prices
Prescription drugs
User charges and fees
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/3223/all-info |
| Text | https://www.congress.gov/116/bills/hr3223/BILLS-116hr3223ih.pdf |
